| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/10/2008 | US20080085898 And 8-substituted 2-(imidazolo[4,5-c]pyridinyl)purines; Janus kinase 3 inhibitors; autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection |
| 04/10/2008 | US20080085897 Inhibitors of cyclic guanosine monophosphate-metabolizing phosphodiesterases (cGMP PDE); cardiac insufficiency, cancer, bladder disorders, or prostate hyperplasia; 2-[2-ethoxy-5-(4-methyl-piperazine-1-sulphonyl)-phenyl]-5,7-dimethyl-3H-imidazo-[5,1-f]-[1,2,4]triazin-4-one for example |
| 04/10/2008 | US20080085890 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof |
| 04/10/2008 | US20080085884 Eating disorders, psychological disorders, sexual disorders, nervous system disorders, sleep disorders, autism; 4-(Benzyloxy)-6'-[3-methyl-3-(methylamino)pyrrolidin-1-yl]-2H-1,3'-bipyridin-2-one for example |
| 04/10/2008 | US20080085883 Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance |
| 04/10/2008 | US20080085862 Natriuretic peptide conjugate using carrier substance |
| 04/10/2008 | US20080085861 Gas1 polypeptides |
| 04/10/2008 | US20080085323 Promotes myoblast differentiation based on identification of cellular processes affected by prelamin A processing |
| 04/10/2008 | US20080085317 Method and Formulation for Treating Resistance to Antihypertensives and Related Conditions |
| 04/10/2008 | US20080085244 comparing levels with untreated ovariectomized animal determining amount of an estrogen to reduce amyloid peptides in brain of an animal without affecting soluble APP level; administering test compound to an ovariectomized non-human animal; beta.17-estradiol reversed ovx-associated levels; Alzheimer's |
| 04/10/2008 | CA2665904A1 Peptides derived from the c2 domain of .epsilon.pkc and methods of use, thereof |
| 04/10/2008 | CA2665435A1 Angiotensin ii receptor antagonist for the prevention or treatment of systemic diseases in cats |
| 04/10/2008 | CA2665398A1 Indazolyl derivatives useful as potassium channel modulating agents |
| 04/10/2008 | CA2665141A1 Composition comprising crustacean gastrolith components and its use |
| 04/10/2008 | CA2664878A1 Di-fluoro containing compounds as cysteine protease inhibitors |
| 04/10/2008 | CA2664621A1 Pyrazine-2-carboxamide derivatives |
| 04/10/2008 | CA2664341A1 Liquid chalcogenide compositions and methods of manufacturing and using the same |
| 04/10/2008 | CA2664119A1 3-pyridinecarboxamide and 2-pyrazinecarboxamide derivatives as hdl-cholesterol raising agents |
| 04/10/2008 | CA2664004A1 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| 04/10/2008 | CA2663361A1 Methods for myocardial imaging in patients having a history of pulmonary disease |
| 04/10/2008 | CA2642455A1 Substituted 4-phenyl piperidines for use as renin inhibitors |
| 04/09/2008 | EP1908781A2 Modulation of immune response and methods based thereon |
| 04/09/2008 | EP1908779A1 Thymosin beta 4 derivatives and use thereof |
| 04/09/2008 | EP1908765A1 Thienopyrimidine derivative |
| 04/09/2008 | EP1908762A2 Organic compounds |
| 04/09/2008 | EP1908761A1 Organic compounds |
| 04/09/2008 | EP1908760A1 Chromane and thiochromane-3-yl-1,3-dihydroimidazoles as inhibitors of dopamine-beta-hydroxylase and methods of their preparation |
| 04/09/2008 | EP1908759A2 3,4-dihydro-3-amino-2H-1-benzopyrane and -benzothiopyrane derivatives as dopamine-beta-hydroxylase Inhibitors and methods of their preparation |
| 04/09/2008 | EP1908755A1 Therapeutic agent for restenosis |
| 04/09/2008 | EP1908753A1 Novel heterocyclidene acetamide derivative |
| 04/09/2008 | EP1908480A1 Interferon- alpha regulator |
| 04/09/2008 | EP1908479A2 Anti-p53 Antibodies |
| 04/09/2008 | EP1908471A1 Tetrahydropyridines as renin inhibitors |
| 04/09/2008 | EP1908469A1 Angiotensin II receptor antagonist for the treatment of systemic diseases in cats |
| 04/09/2008 | EP1908462A2 Dichloroacetate in combination with cardioprotective or hemodynamic drugs |
| 04/09/2008 | EP1908461A1 Use of (1S, 2R) enantiomer of milnacipran for the preparation of a medicine |
| 04/09/2008 | EP1908354A1 Process for production of fermented milk and fermented milk beverage/food |
| 04/09/2008 | EP1907395A1 Abca1 elevating compounds |
| 04/09/2008 | EP1907387A1 An oxime derivative and preparations thereof |
| 04/09/2008 | EP1907362A1 Amide derivatives as kinase inhibitors |
| 04/09/2008 | EP1907359A2 3,5-substituted piperidine derivatives effective on renin-related disorders |
| 04/09/2008 | EP1906983A2 Cynara scolymus extracts, the use thereof ans formulations containing them |
| 04/09/2008 | EP1906966A2 Compositions for reducing the incidence of drug induced arrhythmia |
| 04/09/2008 | EP1906963A2 Method of treating ischemia-reperfusion injury |
| 04/09/2008 | EP1906944A1 Schisandrin b preparation |
| 04/09/2008 | EP1906767A1 Lycopene formulations for the treatment of atherosclerotic conditions |
| 04/09/2008 | EP1450796B1 Benzothiazole derivatives |
| 04/09/2008 | EP1439837B1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 04/09/2008 | EP1414444B1 Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 04/09/2008 | EP1140964B1 Connective tissue growth factor (ctgf) fragment |
| 04/09/2008 | EP1135106B1 Sustained release matrix systems for highly soluble drugs |
| 04/09/2008 | EP1123368B1 Method of extracting lipids from marine and aquatic animal tissues |
| 04/09/2008 | EP1036175B1 Human brain derived kcnq2 potassium channel |
| 04/09/2008 | EP0972028B1 Mutants of vascular endothelial growth factor c (vegf-c) and uses thereof |
| 04/09/2008 | EP0964864B1 Pyrido 2,3-d pyrimidines and 4-aminopyrimidines as inhibitors of cellular proliferation |
| 04/09/2008 | CN101160309A Novel imidazo [1, 5-a] pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 04/09/2008 | CN101160301A Aminoalkyl-amidomethyl-substituted 2- (4-sulphonylamino) -3-hydroxy-3 , 4-dihydro-2h-cromen-6-yl derivatives and their use as potassium channel blockers |
| 04/09/2008 | CN101160290A 7-membered ring compound, process for producing the same, and medicinal use thereof |
| 04/09/2008 | CN101160139A Therapeutic agent for disease with apoptotic degeneration in eye tissue cell containing PEDF and FGF2 |
| 04/09/2008 | CN101160137A Use of CD 25antibody in immunity treatment |
| 04/09/2008 | CN101160136A Hypotensive agent produced by cultivation of lactic acid bacterium |
| 04/09/2008 | CN101156949A Synergistic therapeutic compositions of angiotensin i converting enzyme inhibitors and angiotensin ii antagonists and methods |
| 04/09/2008 | CN101156948A Non neurotoxicity plasminogen incitant for treating palsy |
| 04/09/2008 | CN101156944A Cleavage liquid for preventing and curing nervus energy disease scathing nervus stem cell |
| 04/09/2008 | CN101156936A An administer orally mixed nucleus glycosides as well as its preparing technics |
| 04/09/2008 | CN101156933A A medicine for treating cerebrovascular disease |
| 04/09/2008 | CN101156932A A Chinese medicine capsule for treating cardiac and cerebral vascular diseases and cataptosis sequela |
| 04/09/2008 | CN101156930A A garlic health care capsule for treating cardiac and cerebral vascular diseases and cancer as well as its preparing method |
| 04/09/2008 | CN101156929A Turmeric water-insoluble saponin liposome as well as its preparing method and application |
| 04/09/2008 | CN101156924A A traditional Chinese medicine for treating apoplexy |
| 04/09/2008 | CN101156909A Decompression unction composition and method for producing same |
| 04/09/2008 | CN101156898A Traditional Chinese medicine composition for warming and activating meridian |
| 04/09/2008 | CN101156896A A fumigant medicine for treating angitis and method for making same |
| 04/09/2008 | CN101156894A Mass control method of apricot red injection |
| 04/09/2008 | CN101156893A Mass control method of apricot red injection |
| 04/09/2008 | CN101156880A A preparation method of traditional Chinese medicine ligusticum wallichii injection |
| 04/09/2008 | CN101156875A Cockroach extractive for treating cardiovascular disease, preparation method and its composition |
| 04/09/2008 | CN101156863A A medicine composition for treating cardiac and cerebral vascular disease and its medical usage |
| 04/09/2008 | CN101156851A Nicardipine hydrochloride dispersion piece and method for making same |
| 04/09/2008 | CN101156845A An injection for treating acute myocardial infarct and its sequela |
| 04/09/2008 | CN101156839A White hellebore alcohol and red phenolic acid B compound recipe preparation and its application |
| 04/09/2008 | CN100379751C Regeneration of endogenous myocardial tissue by induction of neovascularization |
| 04/09/2008 | CN100379744C The use of anti-histaminics for acute reduction of elevated intracranial pressure |
| 04/09/2008 | CN100379743C New oxabispidine compound useful in treatment of cardiac arrhythmias |
| 04/09/2008 | CN100379735C 1,2,3,4,7,8-hexahydro-6h-[1,4]diazepino[6,7,1-1j]quinoline derivatives as antipsychotic and antiobesity agents |
| 04/09/2008 | CN100379734C Azaindoles |
| 04/09/2008 | CN100379719C Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 04/09/2008 | CN100379456C Preparation for the prophylaxis of restenosis |
| 04/09/2008 | CN100379448C 蛋白酶抑制剂 Protease inhibitors |
| 04/09/2008 | CN100379431C Preparation method of ginkgo leaf extract freeze dried powder injection |
| 04/09/2008 | CN100379430C Sturgeon chondroition capsule and instant granula preparation method therefor |
| 04/09/2008 | CN100379426C Pyrimidine nucleoside and pharmacy usage of pyrimidine nucleotide precursor |
| 04/09/2008 | CN100379423C Topical medicine composite containing cholinergic drug or calcium channel paralyser |
| 04/09/2008 | CN100379414C Use of an opuntia ficus-indica extract and compounds isolated therefrom for protecting nerve cells |
| 04/09/2008 | CN100379412C Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia |
| 04/09/2008 | CN100379406C Method for preparing tiny pellets of difficult soluble drugs and formulation containing the pellets |
| 04/08/2008 | US7355093 Transgenic rodent for use as tools in identifying modulator for treatment of diabetes, hypertension, cardiovascular and bone disorders |
| 04/08/2008 | US7355069 2-[2-(4-{2-[ethyl(2-fluorobenzyl)amino]-2-oxoethoxy}phenyl)ethoxy]benzoic acid; peroxisome proliferator-activated receptors alfa agonist; antidiabetic, hypotensive agent; obesity, elevated VLDL (Very Low Density Lipoproteins) and reduced HDL (High Density Lipoprotein) concentrations |
| 04/08/2008 | US7355054 Indole derivatives |
| 04/08/2008 | US7355035 Catalytic molecules |